ponatinib,olverembatinib
takeda,otsuka,ascentage pharmaceuticals,incyte,innovent biologics
['ponatinib', 'leusm', 'olverembatinib']
congress | #ash22 | poster weiyang liu @ zhejiang university school of medicine reports on olverembatinib in adult ph-positive all pts with t3121 mutation &amp; relapse. n=10, orr:70%, cmr rate:66.7%, cr rate:75%. olverembatinib was safe in t315i mutated/relapsed pts. #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm